- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-28-0030718

Mancure Medisynthesis Private Limited
About Mancure Medisynthesis Private Limited
Data last updated:
Mancure Medisynthesis Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52603UP2020PTC133142.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Md Rijwan and Snehlata Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh 521 Bicano Colony Surajpur Greater Noida, Uttar Pradesh, India – 201306.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.76 Lakh, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹5,038 (net margin 0.9%) and EBITDA of ₹6,808 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 387% over three years.
Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Mancure Medisynthesis Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0030718).
Company details
Recognitions & Rankings of Mancure Medisynthesis
Contact details
Mancure Medisynthesis Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressKh 521 Bicano Colony Surajpur Greater Noida, Uttar Pradesh, India – 201306
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mancure Medisynthesis is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mancure Medisynthesis Private Limited, buy the company report.
Financials of Mancure Medisynthesis Private Limited
FY 2025 filings availableMancure Medisynthesis Private Limited reported revenue of ₹5.76 Lakh (up 54% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 387% over three years, including 54% growth in the latest year. EBITDA rose 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,808 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,038 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mancure Medisynthesis Private Limited, buy the company report.
Board of directors of Mancure Medisynthesis Private Limited
Mancure Medisynthesis has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Md Rijwan | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
| Snehlata Singh | Director | 22 Aug 2020 | 6 Years 2 Months | Current |
| Urmila | Director | 22 Aug 2020 | 6 Years 2 Months | Current |
Legal cases
Mancure Medisynthesis Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Ipca Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Ipca Laboratories Limited | Pending |
To see the full case history of Mancure Medisynthesis Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mancure Medisynthesis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mancure Medisynthesis Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mancure Medisynthesis Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Md Rijwan was appointed as Director on 15 Mar 2021.
Frequently asked questions
Mancure Medisynthesis is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2020 (6+ years old) and is registered under CIN U52603UP2020PTC133142.
Mancure Medisynthesis has 3 current directors:
- Md Rijwan - Director
- Snehlata Singh - Director
- Urmila - Director
The latest financial statements of Mancure Medisynthesis on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Mancure Medisynthesis is U52603UP2020PTC133142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mancure Medisynthesis has 2 court cases on record: 2 filed against it. 2 are pending.
Mancure Medisynthesis was incorporated on 22 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Md Rijwan was appointed as Director on 15 Mar 2021. Priyanka Dubey ceased to be Director on 15 Mar 2021. Snehlata Singh was appointed as Director on 22 Aug 2020. Mancure Medisynthesis has 4 board changes on record in total.
Yes, Mancure Medisynthesis is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0030718).
The registered office of Mancure Medisynthesis is at Kh 521 Bicano Colony Surajpur Greater Noida, Uttar Pradesh, India – 201306.
Mancure Medisynthesis operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

